Evidence-Based Minireview: Should caplacizumab be used routinely in unselected patients with immune thrombotic thrombocytopenic purpura?

IF 2.9 3区教育学 Q1 EDUCATION, SCIENTIFIC DISCIPLINES

Hematology. American Society of Hematology. Education Program Pub Date : 2022-12-09 DOI:10.1182/hematology.2022000412

George Goshua, Pavan K Bendapudi

引用次数: 4

查看原文本刊更多论文

基于证据的迷你综述:卡普拉珠单抗是否应常规用于未选择的免疫性血栓性血小板减少性紫癜患者?

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Hematology. American Society of Hematology. Education Program EDUCATION, SCIENTIFIC DISCIPLINES-HEMATOLOGY

CiteScore

4.70

自引率

3.30%

发文量

期刊介绍： Hematology, the ASH Education Program, is published annually by the American Society of Hematology (ASH) in one volume per year.